BL

Branden Lee

SP Signal Pharmaceuticals: 14 patents #18 of 207Top 9%
📍 San Diego, CA: #3,133 of 23,606 inventorsTop 15%
🗺 California: #43,449 of 386,348 inventorsTop 15%
Overall (All Time): #343,480 of 4,157,543Top 9%
14
Patents All Time

Issued Patents All Time

Showing 1–14 of 14 patents

Patent #TitleCo-InventorsDate
11292796 Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors Jan Elsner, Roy L. Harris, Deborah Mortensen, Garrick Packard, Patrick Papa +7 more 2022-04-05
10683298 Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors Jan Elsner, Roy L. Harris, Deborah Mortensen, Garrick Packard, Patrick Papa +7 more 2020-06-16
10167290 Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors Jan Elsner, Roy L. Harris, Deborah Mortensen, Garrick Packard, Patrick Papa +7 more 2019-01-01
9771371 Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors Jan Elsner, Roy L. Harris, Deborah Mortensen, Garrick Packard, Patrick Papa +7 more 2017-09-26
9193692 Halogen substituted pyrazines as intermediates of mTOR kinase inhibitors Sophie Perrin-Ninkovic, Roy L. Harris, John Sapienza, Graziella I. Shevlin, Patrick Papa +6 more 2015-11-24
9079900 Methods of synthesis and purification of heteroaryl compounds Roy L. Harris, John Sapienza, Graziella I. Shevlin, Patrick Papa, Garrick Packard +13 more 2015-07-14
8907087 Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors Sophie Perrin-Ninkovic, Roy L. Harris, John Sapienza, Graziella I. Shevlin, Patrick Papa +6 more 2014-12-09
8569494 Methods of synthesis and purification of heteroaryl compounds Roy L. Harris, John Sapienza, Graziella I. Shevlin, Patrick Papa, Garrick Packard +13 more 2013-10-29
8507492 Pyrazino[2,3-b]pyrazine mTOR kinase inhibitor for oncology indications and diseases associated with the mTOR/PI3K/AKT pathway Sophie Perrin-Ninkovic, Roy L. Harris, John Sapienza, Graziella I. Shevlin, Patrick Papa +12 more 2013-08-13
8492381 Pyrazino[2,3-b]pyrazine mTOR kinase inhibitor for oncology indications and diseases associated with the mTOR/PI3K/Akt pathway Sophie Perrin-Ninkovic, Roy L. Harris, John Sapienza, Graziella I. Shevlin, Patrick Papa +12 more 2013-07-23
8372976 Methods of treatment comprising the administration of heteroaryl compounds Deborah Mortensen, Maria Mercedes Delgado Mederos, John Sapienza, Ronald Albers, Roy L. Harris +9 more 2013-02-12
8299056 Aminotriazolopyridines, compositions thereof, and methods of treatment therewith Sogole Bahmanyar, R.J. Bates, Kate Blease, Andrew Antony Calabrese, Thomas Oran Daniel +22 more 2012-10-30
8110578 Pyrazino[2,3-b]pyrazine mTOR kinase inhibitors for oncology indications and diseases associated with the mTOR/PI3K/Akt pathway Sophie Perrin-Ninkovic, Roy L. Harris, John Sapienza, Graziella I. Shevlin, Patrick Papa +12 more 2012-02-07
7981893 Heteroaryl compounds, compositions thereof, and methods of treatment therewith Deborah Mortensen, Maria Mercedes Delgado Mederos, John Sapienza, Ronald Albers, Roy L. Harris +9 more 2011-07-19